ImmunoMind Company

Multi-Omics Driven Development of Effective Cell Therapies
Technology: Artificial Intelligence, Biotechnology, Genetics
Industry: End-to-end Drug Development, United States
Headquarters: Berkeley, California, United States
Founded Date: 2020-01-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 1
Total Funding: 755000
Last Funding Date: 2022-01-01
Last Funding Type: Pre-Seed

Visit Website
contact@immunomind.io
https://twitter.com/immunomind
Register and Claim Ownership